Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03517735
Other study ID # 2017/03
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 17, 2018
Est. completion date March 30, 2019

Study information

Verified date October 2021
Source CMC Ambroise Paré
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study compares automated administration of propofol and remifentanil guided by the Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.


Description:

Automated sedation has the potential to improve patient care after cardiac surgery by adjusting drug doses to the minimum required for efficacy. Indeed, automated and continuous titration may avoid overdosing, improve hemodynamic stability and also decrease the mean time to tracheal extubation. Medsteer SAS developed a controller, EasyTiva device, allowing the closed-loop coadministration of propofol and remifentanil, guided by a Bispectral Index (BIS) monitor. Automated sedation is so facilitated by the BIS which permits continuous monitoring of electrocortical activity. This randomized monocentric trial compares the automated administration with manual intravenous administration of propofol-remifentanil for maintaining adequate depth of hypnosis (BIS 55-75) during sedation after cardiac surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date March 30, 2019
Est. primary completion date March 28, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Cardiac surgical procedure requiring postoperative sedation - Low operative risk : EuroSCORE 2 = 5% - Consent for participation - Affiliation to the social security system Exclusion Criteria: - Pregnant or breastfeeding women - Neurological or muscular disorder - Pacemaker - Hypersensitivity to propofol or remifentanil - Communication difficulties or neuropsychiatric disorder

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EasyTiva (algorithm is the property of Medsteer SAS)
Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.
Drug:
Propofol
The dosage is modified automatically by the device or according to the new medical prescription.
Remifentanil
The dosage is modified automatically by the device or according to the new medical prescription.

Locations

Country Name City State
France CMC Ambroise Paré Neuilly-sur-Seine Ile-de-France

Sponsors (1)

Lead Sponsor Collaborator
CMC Ambroise Paré

Country where clinical trial is conducted

France, 

References & Publications (2)

Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 20 — View Citation

Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Adequate sedation Percentage of time with BIS between 55 and 75 (BIS(55-75)) 6 hours
Secondary Period of too deep sedation Percentage of time with BIS values less than 55 6 hours
Secondary Period of too light sedation Percentage of time with BIS values greater than 75 6 hours
Secondary Incidence of Burst Suppression (bsr) during sedation Presence of Burst Suppression defined by a rate > 10% for at least one minute 6 hours
Secondary Level of sedation Richmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert & calm) 6 hours
Secondary Level of pain during sedation Behavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed :
Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing)
Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted)
Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)
6 hours
Secondary Medical interventions Number and causes of transient or permanent interruptions in automated administration 6 hours
Secondary Hemodynamic status during the sedation period Evolution of hemodynamic parameters (composite : arterial blood pressure in mmHg and heart rate in bpm) 6 hours
Secondary Sedation time Duration of sedation 6 hours
Secondary Delay before awakening Delay between the cessation of infusion of propofol and remifentanil and extubation. 6 hours
Secondary Dose of hypnotic drug Total amount of propofol during sedation period 6 hours
Secondary Dose of analgesic drug Total amount of remifentanil during sedation period 6 hours
Secondary Level of consciousness after extubation Richmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert & calm) 9 hours
Secondary Level of pain after extubation Behavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed :
Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing)
Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted)
Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)
9 hours
Secondary Awareness during the sedation period Awareness standardized questionnaire 48 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas